Abstract
This study evaluated the costs of work-related stress in France. Three illnesses—cardiovascular diseases, depression, musculoskeletal diseases and back pain—that may result from exposure to stress are identified and the proportions of cases attributable to the risk factor are calculated from epidemiological studies. Two methodological hypotheses allow us to provide complementary evaluations of the social cost of occupational stress and raise the ethical questions inherent in the choice of methodology. For the year 2000 our model shows that of a working population of 23.53 million in France some 310,000–393,400 persons (1.3–1.7%) were affected by illnesses attributable to work-related stress, and that 2,300–3,600 persons died as a result of their illness. Work-related stress costs society between €1,167 million and €1,975 million in France, or 14.4–24.2% of the total spending of social security occupational illnesses and work injuries branch.
References
Behrens C, Henke KD (1988) Cost of illness studies: no aid to decision making? Reply to Shiell et al. Health Policy 10:137–141
CNAMTS/DRP (2002) Statistiques financières et technologiques des accidents du travail. Paris
Cooper CL (1985) Organisation du travail et stress d’origine professionnelle. In: Automatisation, organisation du travail et stress d’origine professionnelle. BIT: Genève
Cour des Comptes (2002) La gestion du risque accidents du travail et maladies professionnelle. February
Dhondt S (1998) Time constraints and autonomy at work in the European Union. European Foundation for the Improvement of Living and Working Conditions: Dublin
Drummond M (1992) Cost-of-Illness studies. A major headache? Pharmacoeconomics 2:1–4
Drummond M, O’Brien B, Stoddard G, Torrance G (1997) Methods for the economic evaluation of health care programs, 2nd edn. Oxford University Press: Oxford
Everson SA, Siobhan CM, Lynch JW, Kaplan GA (2002) Epidemiologic evidence for the relation between socioeconomic status and depression, obesity, and diabetes. J Psychosom Res 53:891–895
Gollac M, Volkoff S (2000) Les conditions de travail. La Découverte, Repères: Paris
Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER (1993) The economic burden of depression in 1990. J Clin Psychiatry 54:405–418
Hodgson TA (1989) Cost of illness studies: no aid to decision making? Comments on the second opinion by Shiell et al. Health Policy 11:57–60
Hoogendoorn W, Poppel MV, Bongers P, Koes B, Bouter L (2000) Systematic review of psychosocial factors at work and private life as risk factors for back pain. Spine 25:2114–2125
Imbernon E (2003) Estimation du nombre de cas de certains cancers attribuables à des facteurs professionnels en France. Institut de Veille Sanitaire, Département Santé-Travail
Institut National de la Santé et de la Recherche Publique (INSERM) (2002) Statistiques des causes médicales de décès. INSERM: Paris
Karasek R (1979) Job demands, job decision latitude, and mental strain: Implications for job redesign. Administrative Sci Q 24:285–308
Karasek R, Theorell L (1990) Health work stress, productivity and reconstruction of working life. Wiley: New-York
Kind P, Sorensen J (1993) The costs of depression. Int Clin Psychopharmacol 7:191–195
Koopmanschap MA, Van Ineveld BM (1992) Towards a new approach for estimating indirect costs of disease. Soc Sci Med 34:1005–1010
Kopp P, Fenoglio P (2002) Social cost of drugs in France. Eur Addict Res December
Kortt MA, Langley PC, Cox ER (1998) A review of cost-of-illness studies on obesity. Clin Ther 20:772–779
Le-Pape A, Lecomte T (1996) Aspects socio-économiques de la dépression—Evolution 1980–81/1991–92. CREDES: Paris
Le-Pape A, Lecomte T (1999) Prévalence et prise en charge de la dépression—France 1996–1997. CREDES: Paris
Le-Pen C, Lévy P (1995) Le cot des maladies cardiovasculaires. In: Gangjbakhch I, Ollivier J, Pavie A (eds) Maladie coronaire, approches stratégiques et thérapeutiques. Blackwell: Paris
Letouzey J-P, Genet A, Amoretti R (1996) Cardiologie 2000: Livre Blanc sur la prise en charge des maladies cardiovasculaires en France. Sanesco: Paris
Levi L, Lunde-Jensen P (1996) A model for assessing the costs of stressors at national level, socio-economic costs of work stress in two EU member states. European Foundation for the Improvement of Living and Working Conditions: Dublin p. 82
Mark TL, Woody GE, Juday T, Kleber HD (2001) The economic costs of heroin addiction in the United States. Drug Alcohol Depend 61:195–206
Meltzer D (1997) Accounting for future costs in medical cost-effectiveness analysis. J Health Econ 16:33–64
Mireux D (2002) Harmonisation des données de la protection sociale et prévention des troubles musculo-squelettiques en Europe. Rev Med Assurance Maladie 33:67–78
Niedhammer I, Goldberg M, Leclerc A, David S, Bugel I (1998) Psychosocial factors at work and subsequent depressive symptoms in the gazel cohort. Scand J Work Environ Health 24:197–205
Paoli P, Merllie D (2001) Third European survey on working conditions 2000. European Foundation for the Improvement of Living and Working Conditions: Dublin
Patten SB (2003) International differences in major depression prevalence: what do they mean? J Clin Epidemiol 56:711–716
Ramaciotti D, Perriard J (2001) Les cots du stress en Suisse. Groupe de Psychologie Appliquée de l’université de Neuchâtel & ERGOrama: Genève
Schnall PL, Belkic KL, Landsbergis PA, Baker DB (2000) The workplace and cardiovascular disease. Occup Med 15:324
Shiell A, Gerard K, Donaldson C (1987) Cost of illness studies: no aid to decision making? Health Policy 8:317–323
Siegrist J (1996) Adverse health effects of high-effort/low reward conditions. J Occup Health Psychol 1:27–41
Stoudemire A, Frank R, Hedemark N (1986) The economic burden of depression. Gen Hosp Psychiatry 8:387–394
Tollefson G, Souetre E, Thomander L, Potvin J (1993) Comorbid anxious signs ans symptoms in major depression: impact on functional work capacity and comparative treatment outcomes. Int Clin Psychopharmacol 8:281–293
Acknowledgements
This study was carried out under the aegis of the Economics and Management Laboratory (ex-LATEC, UMR CNRS 5118). It is largely based on postgraduate research by Nathalie Wolff at the University of Burgundy. Very valuable help was provided by S. Dhondt (TNO, The Netherlands), E. Lavaud (CNAMTS Information Department, France), L. Levi and P. Lunde-Jensen, Claude Le Pen (LEGOS, University Paris 9, France), and P. Mossé (LEST, CNRS, France). We express our gratitude to them for their advice and assistance in collecting data. We also thank anonymous referees for their helpful comments. The shortcomings of this study are ours alone.
Conflict of interest:
No information supplied
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Béjean, S., Sultan-Taïeb, H. Modeling the economic burden of diseases imputable to stress at work. Eur J Health Econ 6, 16–23 (2005). https://doi.org/10.1007/s10198-004-0251-4
Issue Date:
DOI: https://doi.org/10.1007/s10198-004-0251-4